Phorbol ester-induced P-glycoprotein phosphorylation and functionality in the HTB-123 human breast cancer cell line

Biochemical Pharmacology

Volumn 56, Issue 6, 1998, Pages 709-718

  Ramachandran, Cheppail ^a   Kunikane, Hiroshi ^a   You, Wei ^a   Krishan, Awtar ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

Drug efflux; Multidrug resistance; P glycoprotein; Phorbol ester; Phosphorylation

Indexed keywords

DIPYRIDAMOLE; DOXORUBICIN; GLYCOPROTEIN P; MONOCLONAL ANTIBODY; PHORBOL 12 ACETATE 13 MYRISTATE; PHORBOL ESTER; VERAPAMIL;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOGENS; DOXORUBICIN; HUMANS; P-GLYCOPROTEIN; PHOSPHORYLATION; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0032530303     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00215-9     Document Type: Article

References (60)

1. Moscow J.A., Cowan K.H. Multidrug resistance. J Natl Cancer Inst. 80:1988;14-20.
2. Endicott J.A., Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem. 58:1989;137-171.
3. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transport. Annu Rev Biochem. 62:1993;385-427.
4. Gottesman M.M., Ambudkar S.V., Ni B., Aran J.M., Sugimoto Y., Cardarelli C.O., Pastan I. Exploiting multidrug resistance to treat cancer. Cold Spring Harb Symp Quant Biol. 59:1994;677-683.
5. Gerlach J.H., Endicott J.A., Juranka P.F., Henderson G., Sarangi F., Deuchars K.L., Ling V. Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature. 324:1986;485-489.
6. Ling V. P-Glycoprotein and resistance to anticancer drugs. Cancer. 69:1992;2603-2609.
7. Van der Bliek A.M., Baas F., Van der Velde-Koerts T., Biedler J.L., Meyers M.B., Ozols R.F., Hamilton T.C., Joenje H., Borst P. Genes amplified and overexpressed in human multidrug-resistant cell lines. Cancer Res. 48:1988;5927-5932.
8. Fojo A.T., Ueda K., Slamon D.J., Poplack D.G., Gottesman M.M., Pastan I. Expression of a multidrug-resistant gene in human tumors and tissues. Proc Natl Acad Sci USA. 84:1987;265-269.
9. Ramachandran C., Sauerteig A., Sridhar K.S., Thurer R.J., Krishan A. MDR-1 gene expression, anthracycline retention and cytotoxicity in human lung tumor cells from refractory patients. Cancer Chemother Pharmacol. 31:1993;431-441.
10. Ramachandran C., Yuan Z.K., Huang X.L., Krishan A. Doxorubicin resistance in human melanoma cells MDR-1 and glutathione S-transferase π gene expression . Biochem Pharmacol. 45:1993;743-751.
11. Krishan A., Sauerteig A., Gordon K., Swinkin C. Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells. Cancer Res. 46:1986;1768-1773.
12. Miller R.L., Grogan T.M., Dalton W.S., Spier C.M., Scheper T.J., Salmon S.E. P-Glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high dose verapamil. J Clin Oncol. 9:1991;17-24.
13. Shalinsky D.R., Andreeff M., Howell S.B. Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro. Cancer Res. 50:1990;7537-7543.
14. Isonishi S., Kirmani S., Kim S., Plaxe S.C., Braly P.S., McClay E.F., Howell S.B. Phase I and pharmacokinetic trial of intraperitoneal etoposide in combination with the multidrug-resistance-modulating agent dipyridamole. J Natl Cancer Inst. 83:1991;621-626.
15. Krishan A. Rapid determination of cellular resistance-related drug efflux in tumor cells. Darzynkiewicz Z., Robinson J.P., Crissman H.A. Methods in Cell Biology. Vol. 42:1994;21-30 Academic Press, New York.
16. Center M.S. Evidence that adriamycin resistance in Chinese hamster lung cells is regulated by phosphorylation of a plasma membrane glycoprotein. Biochem Biophys Res Commun. 115:1983;159-166.
17. Center M.S. Mechanisms regulating cell resistance to adriamycin. Evidence that drug accumulation in resistant cells is modulated by phosphorylation of a plasma membrane glycoprotein. Biochem Pharmacol. 34:1985;1471-1476.
18. Garman D., Albers L., Center M.S. Identification and characterization of a plasma membrane phosphoprotein which is present in Chinese hamster lung cells resistant to adriamycin. Biochem Pharmacol. 32:1983;3633-3637.
19. r 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumor cells. Cancer Res. 47:1987;2860-2865.
20. Bates S.E., Currier S.J., Alvarez M., Fojo A.T. Modulation of P-glycoprotein and drug transport by sodium butyrate. Biochemistry. 31:1992;6366-6372.
21. Chambers T.C., Pohl J., Glass D.B., Kuo F. Phosphorylation by protein kinase C and cyclic AMP-dependent protein kinase of synthetic peptide derived from the linker region of human P-glycoprotein. Biochem J. 299:1994;309-315.
22. Chambers T.C., Zheng B., Kuo J.F. Regulation by phorbol ester and protein kinase C inhibitors and by a protein phosphatase inhibitor (okaidic acid) of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells. Mol Pharmacol. 41:1995;1008-1015.
23. Yang J.M., Chin K.V., Hait W.N. Interaction of P-glycoprotein with protein kinase C in human multidrug resistant carcinoma cells. Cancer Res. 56:1996;3490-3496.
24. Chambers T.C., Pohl J., Raynort R.L., Kuo J.F. Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase C. J Biol Chem. 268:1993;4592-4595.
25. Fine R.L., Patel J., Chabner B. Phorbol ester induces multidrug resistance in human breast cancer cells. Proc Natl Acad Sci USA. 85:1988;582-586.
26. Chambers T.C., Chalikonda I., Eilson G. Correlation of protein kinase C translocation, P-glycoprotein phosphorylation and reduced drug accumulation in multidrug resistant human KB cells. Biochem Biophys Res Commun. 169:1990;253-259.
27. Chambers T.C., McAvoy E.M., Jacobs J.W., Eilon G. Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J Biol Chem. 215:1990;7679-7686.
28. Aftab D.T., Yang J.M., Hait W.N. Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells. Oncol Res. 6:1994;59-70.
29. Germann U.A., Chambers T.C., Ambudkar S.V., Pastan I., Gottesman M.M. Effects of phosphorylation of P-glycoprotein on multidrug resistance. J Bioenerg Biomembr. 27:1995;53-61.
30. Goodfellow H.R., Sardini A., Ruetz S., Callaghan R., Gros P., McNaughton P.A., Higgins C.F. Protein kinase C-mediated phosphorylation does not regulate drug transport by the human multidrug resistance P-glycoprotein. J Biol Chem. 271:1996;13668-13674.
31. Lee Y.-I., Ramachandran C., Kunikane H., Wellham L.L., Krishan A. Modulating effect of tamoxifen, verapamil and trifluoperazine on doxorubicin cytotoxicity in human breast cancer cells. Cell Pharmacol. 2:1995;319-322.
32. Langlois A.J., Holder W.D. Jr, Iglehart J.D., Nelson-Rees W.A., Well S.A. Jr, Bolognesi D.P. Morphological and biochemical properties of a new human breast cancer cell line. Cancer Res. 39:1979;2604-2613.
33. Kunikane H., Krishan A., Ohta S., Kubota N., Takeda Y., Oyama H., Nomura K., Saijo N. Flow cytometric analysis of cellular adriamycin accumulation in small-cell lung cancer cell lines Correlation of P-glycoprotein expression, cytotoxicity and intracellular distribution . Cell Pharmacol. 1:1995;293-300.
34. + gradient-stimulated uptake. J Biol Chem. 252:1977;1990-1997.
35. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1979;248-254.
36. Chan H.S.L., Bradley G., Thorner P., Haddad G., Gallie B.L., Ling V. Methods in laboratory investigation. A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines. Lab Invest. 59:1988;870-875.
37. Noonan K.E., Beck C., Holzmayer T.A., Chin J.E., Wunder J.S., Andrulis I.L., Gazdar A.F., Willman C.L., Griffith B., Von Hoff D.D., Roninson I.B. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA. 87:1990;7160-7164.
38. Krishan A., Sauerteig A., Wellham L.L. Flow cytometric studies on modulation of anthracycline retention by phenothiazines. Cancer Res. 45:1985;1046-1051.
39. Bachur N.R., Moore A.L., Bernstein J.G., Liu A. Tissue distribution and disposition of daunomycin (NSC-82151) in mice Fluorometric and isotopic methods . Cancer Chemother Rep. 54:1970;89-94.
40. Ganapathi R., Reiter W., Krishan A. Comparative studies on intracellular adriamycin levels and cytotoxicity in sensitive and resistant P388 leukemia cells. J Natl Cancer Inst. 68:1982;1027-1032.
41. Blobe G.C., Sachs C.W., Khan W.A., Fabbro D., Stabel S., Westel W.C., Obeid L.M., Fine R.L., Hannun Y.A. Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. J Biol Chem. 268:1993;658-666.
42. Schneider J., Bak M., Efferth T., Kaufmann M., Mattern J., Volm M. P-Glycoprotein expression in treated and untreated human breast cancer. Br J Cancer. 60:1989;815-818.
43. Ro H., Sahin A., Ro J.Y., Fritsche H., Hortobagyi G., Blick M. Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer. Hum Pathol. 21:1990;787-791.
44. Keith W.N., Sallard S., Brown R. Expression of mdr1 and gst-π in human breast tumours Comparison to in vitro chemosensitivity . Br J Cancer. 61:1990;712-716.
45. Wishart G.C., Plumb J.A., Going J.J., McNicol A.M., McArdle C.S., Tsuruo T., Kaye S.B. P-Glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies. Br J Cancer. 62:1990;758-761.
46. Sanfilippo O., Ronchi E., DeMarco C., Di Fronzo G., Silvestrini R. Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine. Eur J Cancer. 27:1991;155-158.
47. Wallner J., Depisch D., Hopfner M., Haider K., Spona J., Ludwig H., Pirker R. MDR1 gene expression and prognostic factors in primary breast carcinomas. Eur J Cancer. 27:1991;1352-1355.
48. Dixon A.J., Bell J., Ellis I.O., Elston C.W., Blamey R.W. P-Glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy. Br J Cancer. 66:1992;537-541.
49. Hennequin E., Delvincourt C., Pourny C., Jardillier J.-C. Expression of mdr1 gene in human breast primary tumors and metastases. Breast Cancer Res Treat. 26:1993;267-274.
50. Verelle P., Meissonnier F., Fonck Y., Feillel V., Dionet C., Kwiatkowski F., Plagne R., Chassagne J. Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. J Natl Cancer Inst. 83:1991;111-116.
51. Veneroni S., Zaffaroni N., Daidone M.G., Benini E., Villa R., Silvestrini R. Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers. Eur J Cancer. 30A:1994;1002-1007.
52. Linn S.C., Giaccone G., van Diest P.J., Blokhuis W.M.D., van der Valk P., van Kalken C.K., Kuiper C.M., Pinedo H.M., Baak J.P.A. Prognostic relevance of P-glycoprotein expression in breast cancer. Ann Oncol. 6:1995;679-685.
53. Filipits M., Suchomel R.W., Dekan G., Haider K., Valdimarsson G., Depisch D., Pirker R. MRP and MDR1 gene expression in primary breast carcinomas. Clin Cancer Res. 2:1996;1231-1237.
54. Xie X.-Y., Robb D., Chow S., Hedley D.W. Discordant P-glycoprotein antigen expression and transport function in acute myeloid leukemia. Leukemia. 9:1995;1882-1887.
55. Leith C.P., Chen I.-M., Kopecky K.J., Appelbaum F.R., Head D.R., Godwin J.E., Weick J.K., Willman C.L. Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry Identification of discordant MDR-/efflux+ and MDR1+/efflux cases . Blood. 86:1995;2329-2342.
56. Carlsen S.A., Till J.E., Ling V. Modulation of drug permeability in Chinese hamster ovary cells - Possible role for phosphorylation of surface glycoproteins. Biochim Biophys Acta. 467:1977;238-240.
57. Chaudhary P.M., Roninson I.B. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists. Oncol Res. 4:1992;281-290.
58. Richert N., Aldvin L., Nitecki D., Gottesman M.M., Pastan I. Modulation of P-glycoprotein in multidrug-resistant KB cells. Biochemistry. 4:1988;7607-7613.
59. Mickley L.A., Bates S.E., Richert N.D., Currier S., Tanaka S., Foss F., Rosen N., Fojo A.T. Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents. J Biol Chem. 264:1989;18031-18040.
60. Drew L., Groome N., Warr J.R., Rumshy M.G. Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment A potential role for protein kinase C in reducing drug efflux . Oncol Res. 8:1996;249-257.